• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型具有钙内流阻断活性的二氢吡啶化合物NPK - 1886对心血管的影响

Cardiovascular effects of NPK-1886, a new dihydropyridine compound with calcium entry blocking activity.

作者信息

Nagura J, Murayama B, Harada N, Suzuki K, Miyano T, Yajima M, Takeya K

出版信息

Jpn J Pharmacol. 1986 Mar;40(3):399-409. doi: 10.1254/jjp.40.399.

DOI:10.1254/jjp.40.399
PMID:3712868
Abstract

The cardiovascular effect of NPK-1886 (NPK), a novel photostable dihydropyridine compound, was studied by comparing it with that of nifedipine (Nif). In normal Wistar rats (NWR), systolic blood pressure was only slightly depressed by NPK or Nif, while in three types of hypertensive rats (i.e., spontaneously hypertensive rats (SHR), renal hypertensive rats (RHR) and DOCA-saline-induced hypertensive rats (DOC-Na-R)), the hypotensive potency of NPK was more than or equal to that of Nif. The effectiveness of NPK on the normal and hypertensive models was in the following order: DOC-Na-R, RHR, SHR, NWR. Coronary perfusion flow in Langendorff's heart was increased almost the same extent by NPK and Nif. On isolated rabbit aortic strips, the antagonistic potencies of NPK, like those of Nif, were greater for calcium than for norepinephrine, serotonin and angiotensin II. The negative ino- and chronotropic potency of NPK in isolated guinea-pig right atria was less than that of Nif. The slow membrane action potentials of guinea-pig papillary muscle were suppressed by NPK, but less than by Nif, with manifestations of a reduction of Vmax and AP-duration. These results indicate that NPK has a potent hypotensive effect on hypertensive models and a weaker cardiac inhibition. The general toxicity of NPK was lower than that of Nif.

摘要

通过将新型光稳定二氢吡啶化合物NPK - 1886(NPK)与硝苯地平(Nif)进行比较,研究了其心血管效应。在正常Wistar大鼠(NWR)中,NPK或Nif仅使收缩压略有降低,而在三种高血压大鼠(即自发性高血压大鼠(SHR)、肾性高血压大鼠(RHR)和DOCA - 盐水诱导的高血压大鼠(DOC - Na - R))中,NPK的降压效力大于或等于Nif。NPK对正常和高血压模型的有效性顺序如下:DOC - Na - R、RHR、SHR、NWR。NPK和Nif使Langendorff心脏的冠状动脉灌注流量增加的程度几乎相同。在离体兔主动脉条上,NPK的拮抗效力与Nif一样,对钙的作用大于对去甲肾上腺素、5 - 羟色胺和血管紧张素II的作用。NPK对离体豚鼠右心房的负性变力和变时效力小于Nif。豚鼠乳头肌的慢膜动作电位受到NPK的抑制,但程度小于Nif,表现为Vmax和动作电位时程降低。这些结果表明,NPK对高血压模型有强效降压作用,对心脏的抑制作用较弱。NPK的一般毒性低于Nif。

相似文献

1
Cardiovascular effects of NPK-1886, a new dihydropyridine compound with calcium entry blocking activity.新型具有钙内流阻断活性的二氢吡啶化合物NPK - 1886对心血管的影响
Jpn J Pharmacol. 1986 Mar;40(3):399-409. doi: 10.1254/jjp.40.399.
2
Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.新型二氢吡啶衍生物(E)-3-苯基-2-丙烯-1-基-1,4-二氢-2,6-二甲基-4-(3-硝基苯基)吡啶-3,5-二羧酸甲酯的降压及心血管效应
Arzneimittelforschung. 1986;36(1):29-34.
3
Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors.氨氯地平在体外血管平滑肌和心肌中的钙通道阻滞特性:血管二氢吡啶受体电压调节的证据。
J Cardiovasc Pharmacol. 1987 Jan;9(1):110-9.
4
Antihypertensive activity of OPC-13340, a new potent and long-acting dihydropyridine calcium antagonist, in rats.新型强效长效二氢吡啶类钙拮抗剂OPC-13340对大鼠的降压活性
J Cardiovasc Pharmacol. 1990 May;15(5):836-44. doi: 10.1097/00005344-199005000-00021.
5
Effects of nilvadipine on the cardiovascular system in experimental animals.尼伐地平对实验动物心血管系统的影响。
Arzneimittelforschung. 1988 Nov;38(11):1605-18.
6
Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists.
Eur J Pharmacol. 1988 Jan 27;146(1):35-43. doi: 10.1016/0014-2999(88)90484-0.
7
[Vasodilator effects of LF 2.0254, a new 1,4-dihydropyridine. Comparison with nifedipine].[新型1,4 - 二氢吡啶类化合物LF 2.0254的血管舒张作用。与硝苯地平的比较]
Therapie. 1989 May-Jun;44(3):203-8.
8
Cardiovascular pharmacology of nicardipine in animals.尼卡地平在动物体内的心血管药理学
Br J Clin Pharmacol. 1985;20 Suppl 1(Suppl 1):7S-22S. doi: 10.1111/j.1365-2125.1985.tb05140.x.
9
Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.新型强效长效抗高血压钙通道阻滞剂(±)-3-乙基、5-甲基、2-([2-(甲酰氨基)-乙基]-硫代甲基)-6-甲基-4-(3-硝基苯基)-1,4-二氢吡啶-3,5-二羧酸酯的心血管活性
Arzneimittelforschung. 1992 Jan;42(1):1-8.
10
Selective cardiodepressant activity of fluodipine, a fluorenone-1,4-dihydropyridine derivative.芴酮-1,4-二氢吡啶衍生物氟桂利嗪的选择性心脏抑制活性。
Eur J Pharmacol. 1998 Oct 23;359(2-3):161-70. doi: 10.1016/s0014-2999(98)00654-2.

引用本文的文献

1
Cardiovascular effects of two new calcium antagonists, PY 108-068 and PN 200-110, in conscious spontaneously hypertensive rats.两种新型钙拮抗剂PY 108 - 068和PN 200 - 110对清醒自发性高血压大鼠的心血管效应。
Br J Pharmacol. 1988 Jan;93(1):176-84. doi: 10.1111/j.1476-5381.1988.tb11419.x.